Skip to content
The Nexus
HEALTHAug 1 · 11:00 UTCNPR NEWSSydney Lupkin

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is set to decide on Moderna's mRNA-based flu shot, potentially the first of its kind, which could significantly impact the biotech industry. The decision involves technology that RFK Jr. has questioned.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
FDAorganizationModernaorganizationmRNA-based flu shottopicRFK Jr.personbiotech industrytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned · The Nexus